genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
05 April 2024
Interim Presentation 31 December 2023
View all reports >
Tuesday August 06, 2024
genedrive shares down 10% after CEO departure
Friday August 02, 2024
Small-cap Movers: UK Oil & Gas lights up on innovative hydrogen pans
Wednesday July 31, 2024
Genedrive shares rally after netting NICE recommendation
View all news >
This site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.
Don't show this again